Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hypothyroidism in the Elderly: Who Should Be Treated and How?
Calsolaro V, Niccolai F, Pasqualetti G, Tognini S, Magno S, Riccioni T, Bottari M, Caraccio N, Monzani F. Calsolaro V, et al. Among authors: riccioni t. J Endocr Soc. 2018 Nov 19;3(1):146-158. doi: 10.1210/js.2018-00207. eCollection 2019 Jan 1. J Endocr Soc. 2018. PMID: 30607373 Free PMC article. Review.
Animal models of Parkinson׳s disease: Effects of two adenosine A2A receptor antagonists ST4206 and ST3932, metabolites of 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535).
Stasi MA, Minetti P, Lombardo K, Riccioni T, Caprioli A, Vertechy M, Di Serio S, Pace S, Borsini F. Stasi MA, et al. Among authors: riccioni t. Eur J Pharmacol. 2015 Aug 15;761:353-61. doi: 10.1016/j.ejphar.2015.03.070. Epub 2015 Apr 30. Eur J Pharmacol. 2015. PMID: 25936513
Synthesis and biological evaluation of metabolites of 2-n-butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535), a potent antagonist of the A2A adenosine receptor for the treatment of Parkinson's disease.
Piersanti G, Bartoccini F, Lucarini S, Cabri W, Stasi MA, Riccioni T, Borsini F, Tarzia G, Minetti P. Piersanti G, et al. Among authors: riccioni t. J Med Chem. 2013 Jul 11;56(13):5456-63. doi: 10.1021/jm400491x. Epub 2013 Jun 24. J Med Chem. 2013. PMID: 23789814
5-HT6 pharmacology inconsistencies.
Borsini F, Bordi F, Riccioni T. Borsini F, et al. Among authors: riccioni t. Pharmacol Biochem Behav. 2011 Apr;98(2):169-72. doi: 10.1016/j.pbb.2010.12.021. Epub 2010 Dec 28. Pharmacol Biochem Behav. 2011. PMID: 21192969 Review.
5-HT6 receptor characterization.
Riccioni T. Riccioni T. Int Rev Neurobiol. 2010;94:67-88. doi: 10.1016/B978-0-12-384976-2.00003-4. Int Rev Neurobiol. 2010. PMID: 21081202 Review. No abstract available.
A placental growth factor variant unable to recognize vascular endothelial growth factor (VEGF) receptor-1 inhibits VEGF-dependent tumor angiogenesis via heterodimerization.
Tarallo V, Vesci L, Capasso O, Esposito MT, Riccioni T, Pastore L, Orlandi A, Pisano C, De Falco S. Tarallo V, et al. Among authors: riccioni t. Cancer Res. 2010 Mar 1;70(5):1804-13. doi: 10.1158/0008-5472.CAN-09-2609. Epub 2010 Feb 9. Cancer Res. 2010. PMID: 20145150 Free article.
27 results